Éric Leblanc

9.5k total citations · 1 hit paper
251 papers, 6.0k citations indexed

About

Éric Leblanc is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Éric Leblanc has authored 251 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Obstetrics and Gynecology, 111 papers in Reproductive Medicine and 78 papers in Surgery. Recurrent topics in Éric Leblanc's work include Endometrial and Cervical Cancer Treatments (105 papers), Ovarian cancer diagnosis and treatment (91 papers) and Uterine Myomas and Treatments (44 papers). Éric Leblanc is often cited by papers focused on Endometrial and Cervical Cancer Treatments (105 papers), Ovarian cancer diagnosis and treatment (91 papers) and Uterine Myomas and Treatments (44 papers). Éric Leblanc collaborates with scholars based in France, United States and Canada. Éric Leblanc's co-authors include Denis Querleu, Fabrice Narducci, B. Castelain, Philippe Morice, Émile Daraï, Patrice Mathevet, Denis Querleu, Fabrice Lécuru, H. Marret and Éric Lambaudie and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Éric Leblanc

234 papers receiving 5.8k citations

Hit Papers

Detection rate and diagno... 2011 2026 2016 2021 2011 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Éric Leblanc 3.5k 2.7k 1.9k 1.6k 673 251 6.0k
Thomas W. Burke 4.3k 1.2× 3.3k 1.3× 2.2k 1.2× 2.0k 1.2× 990 1.5× 233 9.1k
Giorgio Bogani 3.8k 1.1× 3.0k 1.1× 1.7k 0.9× 1.2k 0.8× 573 0.9× 335 6.3k
Lars‐Christian Horn 1.5k 0.4× 895 0.3× 944 0.5× 1.1k 0.7× 679 1.0× 253 4.5k
Gary L. Goldberg 1.4k 0.4× 1.1k 0.4× 1.0k 0.5× 990 0.6× 429 0.6× 211 4.3k
Rodrigue Mortel 1.9k 0.5× 1.4k 0.5× 939 0.5× 1.3k 0.8× 348 0.5× 122 4.6k
Emma J. Crosbie 2.2k 0.6× 1.5k 0.6× 999 0.5× 1.4k 0.8× 400 0.6× 212 6.1k
Claus Høgdall 1.8k 0.5× 3.0k 1.1× 1.0k 0.6× 508 0.3× 412 0.6× 284 6.0k
John R. van Nagell 2.8k 0.8× 3.7k 1.4× 1.6k 0.9× 1.2k 0.7× 604 0.9× 226 7.4k
Sepp Leodolter 996 0.3× 870 0.3× 1.2k 0.6× 1.9k 1.2× 456 0.7× 181 5.5k
Sadaf Ghaem‐Maghami 1.2k 0.3× 1.0k 0.4× 767 0.4× 602 0.4× 202 0.3× 131 4.4k

Countries citing papers authored by Éric Leblanc

Since Specialization
Citations

This map shows the geographic impact of Éric Leblanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Leblanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Leblanc more than expected).

Fields of papers citing papers by Éric Leblanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Leblanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Leblanc. The network helps show where Éric Leblanc may publish in the future.

Co-authorship network of co-authors of Éric Leblanc

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Leblanc. A scholar is included among the top collaborators of Éric Leblanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Leblanc. Éric Leblanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wisztorski, Maxence, Soulaimane Aboulouard, Marie Duhamel, et al.. (2023). Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. Cell Death and Disease. 14(9). 644–644. 8 indexed citations
2.
Fournier, Clémence, Éric Leblanc, Marie‐Cécile Le Deley, et al.. (2023). Diagnostic Value of the Texture Analysis Parameters of Retroperitoneal Residual Masses on Computed Tomographic Scan after Chemotherapy in Non-Seminomatous Germ Cell Tumors. Cancers. 15(11). 2997–2997. 2 indexed citations
3.
Classe, Jean‐Marc, Pierre Méeus, Éric Leblanc, et al.. (2023). #876 Hyperthermic intraperitoneal chemotherapy in platinum-sensitive relapsed epithelial ovarian cancer: the chipor randomised phase III trial. A29.1–A29. 4 indexed citations
4.
Martínez-Gómez, Carlos, Emilie Bogart, Marie‐Cécile Le Deley, et al.. (2023). Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne’s Thread in Early Cervical Cancer Treatment?. Cancers. 15(5). 1570–1570. 2 indexed citations
5.
Berthet, Aurélie, et al.. (2022). Total parietal peritonectomy for 61 patients: a retrospective study. European Journal of Gynaecological Oncology. 43(1). 17–17. 1 indexed citations
6.
Aboulouard, Soulaimane, Maxence Wisztorski, Marie Duhamel, et al.. (2021). In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer. Cell Reports Medicine. 2(6). 100318–100318. 19 indexed citations
7.
Balaya, Vincent, Benedetta Guani, Philippe Morice, et al.. (2021). Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer: A post-hoc analysis of SENTICOL I and SENTICOL II cohorts. Gynecologic Oncology. 164(1). 53–61. 26 indexed citations
8.
Rodrigues, Manuel, Florence Joly, Isabelle Laure Ray-Coquard, et al.. (2021). 746P Real-world clinical outcomes of patients with de novo advanced high-grade epithelial ovarian cancer eligible to niraparib maintenance in France. Annals of Oncology. 32. S741–S742.
9.
Centini, Gabriele, et al.. (2020). Glassy cell carcinoma: is surgical treatment withpreservation of the uterus a therapeutic option. European Journal of Gynaecological Oncology. 41(1). 121–121. 1 indexed citations
10.
Fernandes, R, Cristina Antón, André Lopes, et al.. (2020). Persistent postoperative ascites successfully identified and treated with laparoscopic indocyanine green fluorescence. International Journal of Gynecological Cancer. 30(8). 1250–1251. 3 indexed citations
11.
Bataille, B., Alexandre Escande, Fabrice Narducci, et al.. (2019). Intracavitary Preoperative Brachytherapy Followed By Whertheim-Type Hysterectomy in Localized Cervical Cancer: Clinical Data and Toxicity Results from a Single Institution Experience. International Journal of Radiation Oncology*Biology*Physics. 105(1). E319–E320. 2 indexed citations
12.
Chiannilkulchai, Nuchanard, Patricia Pautier, Catherine Genestie, et al.. (2017). Networking for ovarian rare tumors: a significant breakthrough improving disease management. Annals of Oncology. 28(6). 1274–1279. 18 indexed citations
13.
Nickers, P., Emmanuelle Tresch, B. Castelain, et al.. (2015). Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report. Reports of Practical Oncology & Radiotherapy. 20(5). 385–392. 3 indexed citations
14.
Morice, Philippe, et al.. (2007). CommuniquéBulletin de veille 2007Recommandations pour la pratique cliniquePrise en charge des patientes atteintes de tumeurs épithéliales malignes de l’ovaire : traitement chirurgical. Bulletin du Cancer. 94(11). 995–1001. 3 indexed citations
15.
Leblanc, Éric, et al.. (2005). Pretherapeutic laparoscopic staging of locally advanced cervical carcinomas: Technique and results. Gynecologic Oncology. 99(3). S157–S158. 5 indexed citations
16.
Resbeut, M., Christine Haie‐Méder, A Bataillard, et al.. (2002). Standards, Options et Recommandations pour la prise en charge de patientes atteintes de cancer invasif du col utérin (stade non métastatique) (version abrégée). Gynécologie Obstétrique & Fertilité. 30(7-8). 631–648. 2 indexed citations
17.
Ansquer, Y., Éric Leblanc, Philippe Morice, et al.. (2001). Neoadjuvant chemotherapy for unresectable ovarian carcinoma. Cancer. 91(12). 2329–2334. 5 indexed citations
18.
Ansquer, Y., Éric Leblanc, Philippe Morice, et al.. (2001). Neoadjuvant chemotherapy for unresectable ovarian carcinoma. Cancer. 91(12). 2329–2334. 128 indexed citations
19.
Taïeb, S., et al.. (2000). [Predictive value of abdominopelvic scan for optimal surgery of ovarian carcinoma].. PubMed. 29(6). 555–63. 3 indexed citations
20.
Querleu, Denis, Éric Leblanc, & B. Castelain. (1990). [Pelvic lymphadenectomy under celioscopic guidance].. PubMed. 19(5). 576–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026